Insight
is our reward

Publications in Pembrolizumab by NOMIS researchers

NOMIS Researcher(s)

Published in

September 19, 2019

Proteomic profiling of melanomas from patients undergoing immunotherapy reveals key mediators of tumor immunogenicity.

Research field(s)
Health Sciences, Biomedical Research, Developmental Biology